Protein C Deficiency

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Protein C Deficiency trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06590974

A Study of Freeze-dried Human Protein C Concentrate (TAK-662) in Participants With Congenital Protein C Deficiency

This study is conducted in Japan of Freeze-dried Human Protein C Concentrate (TAK-662) used to treat participants with congenital protein C deficiency. The mai…

Japan7 participantsStarted 2024-09-06

Treatment: Freeze-dried Human Protein C Concentrate

All recent trials (31 shown)

CompletedPhase 1

NCT05182125

Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Chimp Adenovirus Vaccines Expressing Clade C g…

The purpose of this study is to evaluate the safety and immunogenicity of HIV-1 vaccines based on chimpanzee serotypes of adenovirus expressing clade C gp140 an…

South Africa34 participantsStarted 2021-11-25

Treatment: AdC6-HIVgp140, AdC7-HIVgp140

CompletedPhase 1/2

NCT04984889

A Study of TAK-662 for Japanese Patients With Congenital Protein C Deficiency

Pharmacokinetic Part: This study is for Japanese participants with congenital protein C deficiency. The main aim of this study is to check how much TAK-662 sta…

Japan5 participantsStarted 2021-09-07

Treatment: TAK-662

Protein C Deficiency

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study of Freeze-dried Human Protein C Concentrate (TAK-662) in Participants With Congenital Protein C Deficiency

All recent trials (31 shown)

Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Chimp Adenovirus Vaccines Expressing Clade C g…

A Study of TAK-662 for Japanese Patients With Congenital Protein C Deficiency

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study of Freeze-dried Human Protein C Concentrate (TAK-662) in Participants With Congenital Protein C Deficiency

All recent trials (31 shown)

Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Chimp Adenovirus Vaccines Expressing Clade C g…

A Study of TAK-662 for Japanese Patients With Congenital Protein C Deficiency

Early Check: Expanded Screening in Newborns

A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya

A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)…

Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mo…

Epidemiology of Surfactant Protein-B Deficiency

Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults

Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy…

Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Va…

Evaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV Vaccine…

Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the Unite…

A One-stop Shop for the Same Day Diagnosis and Management of TB and HIV

Genetic Regulation of Surfactant Deficiency

Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency

Retrospective Study to Capture Dosing and Treatment Outcome Data in Participants With Severe Congenital Protein C Defici…

5-methyltetrahydrofolate Survival and Inflammation in ESRD Patients

Ceprotin Treatment Registry

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

The Second Multicenter Hemophilia Cohort Study